Clinical Trials Logo

Fecal Incontinence clinical trials

View clinical trials related to Fecal Incontinence.

Filter by:

NCT ID: NCT01548976 Completed - Clinical trials for Urinary Incontinence

Validation of a French Version of the PISQ-R

Start date: April 2012
Phase: N/A
Study type: Observational

The main objective of this study is to perform the linguistic validation of the french version of the PISQ-R questionnaire in a population of sexually active (or not) patients who have undergone surgery (or not) for stress urinary incontinence or genital prolapse.

NCT ID: NCT01528995 Completed - Fecal Incontinence Clinical Trials

Treatment of Fecal Incontinence After Obstetric Anal Sphincter Injuries

KISS
Start date: February 2012
Phase: N/A
Study type: Interventional

Fecal incontinence (FI), the involuntary loss of solid or liquid stool, is a stigmatising condition. It can have a distressing impact and restriction on quality of life. Obstetric-related fecal incontinence may occur early after childbirth. Previous obstetric injury is a major cause of fecal incontinence in older women. When conservative treatment fails, surgery may be an option. Both sacral nerve modulation and anal bulking injections is minimal invasive surgical alternatives. Step one in SNM is a trial period of temporary stimulation. If the test is successful, the patient can have an implantable stimulator (step 2). Transanal submucosal bulking injection of collagen is also a possible treatment option and can be an effective treatment for faecal incontinence. The purpose of this study is to compare the efficacy of sacral nerve stimulation to anal bulking injections in women with fecal incontinence after obstetric sphincter injuries (OASIS), through a multicenter blinded, randomized controlled trial.

NCT ID: NCT01523522 Completed - Fecal Incontinence Clinical Trials

Autologous Myoblast Intrasphincteric Injection for Fecal Incontinence

MIAS
Start date: February 2012
Phase: Phase 2/Phase 3
Study type: Interventional

This project aims to offer autologous muscle-derived progenitor cell injection as an efficient mini-invasive surgical therapy that would be simple for the patient and could be used in a majority of cases, including in young women in the post-partum. This approach may provide efficient tissue repair of the striated anal sphincter which is not permitted by existing therapies. This innovative therapy may ultimately be proposed after failure of the common treatments and before an high-risk invasive surgical intervention. Besides, injection of muscle-derived progenitor cells in animals has shown very encouraging results of the sphincter function assessed ex vivo. Hence, a high benefit may be expected with this approach.

NCT ID: NCT01475474 Completed - Bowel Incontinence Clinical Trials

A Study to Evaluate the Safety, Tolerability and Effectiveness of the Renew Insert in Treating Accidental Bowel Leakage

REST
Start date: December 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether the use of the Renew Insert is effective, tolerable and safe in the treatment of accidental bowel leakage due to bowel incontinence.

NCT ID: NCT01421823 Withdrawn - Clinical trials for Idiopathic Fecal Incontinence

A Double Blinded Study to Examine the Effect of Alpha Agonist Ointment on Fecal Incontinence in Patients With Idiopathic Fecal Incontinence

Start date: August 2011
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to assess the effect and safety of alpha agonist ointment on fecal incontinence severity in patients with idiopathic fecal incontinence.

NCT ID: NCT01406925 Completed - Fecal Incontinence Clinical Trials

Safety and Tolerability of a Single Intra-anal Dose of NRL001 in Healthy Volunteers

Start date: April 2007
Phase: Phase 1
Study type: Interventional

This study is conducted to explore the safety and tolerability and plasma pharmacokinetics of NRL001 after single intra-anal dose of 1mL cream at increasing concentrations.

NCT ID: NCT01380132 Completed - Fecal Incontinence Clinical Trials

Safety and Efficacy of Anorectal Application of Dx-gel for Treatment of Anal Incontinence

Start date: February 2004
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether anorectal application of Nasha Dx is safe and effective for treatment of anal incontinence.

NCT ID: NCT01310426 Completed - Fecal Incontinence Clinical Trials

Risk Factors for Anal Sphincter Damage During Vaginal Delivery

AnaSphRF
Start date: March 2011
Phase: N/A
Study type: Observational

Vaginal delivery may cause various levels of damage to the anal sphincter. According to the literature, one third - two third of women diagnosed with 3rd degree rupture during vaginal delivery suffer from fecal incontinence. This has an adverse effect on the quality of life. Different risk factors such as: first births, instrumental delivery, high birth weight, prolonged second stage, epidural anesthesia etc. were assessed and found to be associated with anal sphincter disruption. The purpose of this study is to assess risk factors for anal sphincter disruption by new methods such as three-Dimensional transperineal ultrasound (3D transperineal US).

NCT ID: NCT01300884 Completed - Constipation Clinical Trials

Sierra High Definition Ano-Rectal Manometry

Start date: February 2008
Phase:
Study type: Observational

Hypotheses: High definition manometry (HDM) is safe and feasible in humans; HDM accurately characterizes anorectal anatomy and function in healthy humans; HDM provides comparable information regarding the structure and function of the anorectal region, to that obtained from ano-rectal manometry and anal ultrasonography (AUS), in patients with fecal incontinence or constipation. Methods: 20 healthy volunteers, 20 patients with fecal incontinence, 20 patients with constipation will be recruited. Because anorectal disorders are more common in women, the investigators will recruit approximately 8 men and 12 women in each group. Each subject will undergo anorectal manometry, anal ultrasound and high definition manometry. Data Analysis: Spearman correlational analysis will be performed to compare the parameters listed above. Also, the diagnostic yield of anal ultrasonography vs HDM in identifying anatomic sphincter defects will be assessed.

NCT ID: NCT01275560 Completed - Anal Incontinence Clinical Trials

Does the Negativation of the Glucose Hydrogen Breath Test Come Along With a Reduction of the Symptoms of Gaz Incontinence ?

Start date: January 2011
Phase: Phase 3
Study type: Interventional

The objectives of this work are: 1/to estimate the frequency of a positive glucose breath test in favour of a small intestinal bacterial overgrowth in a population of patients consulting for gaz incontinence by comparison to a population of control subjects; 2/to estimate versus a conventional treatment the efficiency of an antibiotic treatment; in case of small intestinal bacterial overgrowth diagnosed by the glucose breath test, to improve gaz incontinence